Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
James Kinley Insider Profile
4 Followers
James Kinley, Chief Financial Officer at Medicure, holds 1.05M shares in Algernon Pharmaceuticals (Ticker: AGNPF), holds 47.10K shares in Medicure (Ticker: TSE:MPH). Most recently, James Kinley Bought ― shares of Algernon Pharmaceuticals on Aug 08, 2024 for an estimated value of 27.00K.
Profitable Transactions
1 out of 4 Profitable Transactions
Average Return
-13.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that James Kinley holds in companies
Most Profitable Insider Trade
The most profitable trade made by James Kinley
James Kinley's Trading History
Medicure
Jun 11, 2018
Chief Financial Officer
Uninformative Sell
13.50K
C$42.39K
Algernon Pharmaceuticals
Aug 08, 2024
Chief Financial Officer
Informative Buy
27.00K
$57.67K
List of latest transactions for each holding click on a transaction to see James Kinley's performance on stock
You May Also Like
James Kinley insider profile FAQ
What is the percentage of profitable transactions made by James Kinley?
The percentage of profitable transactions made by James Kinley is 25%.
What is the average return per transaction made by James Kinley?
The average return per transaction made by James Kinley is -13.70%.
What stocks does James Kinley hold?
James Kinley holds: TSE:MPH, AGNPF stocks.
What was James Kinley’s latest transaction?
James Kinley latest transaction was an Informative Buy of $27.00K.
What was James Kinley's most profitable transaction?
James Kinley’s most profitable transaction was an Informative Buy of TSE:MPH stock on September 29, 2014. The return on the trade was 73.60%.
What is James Kinley's role in Medicure?
James Kinley's role in Medicure is Chief Financial Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.